1. Home
  2. BEAM vs VAC Comparison

BEAM vs VAC Comparison

Compare BEAM & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.64

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Marriott Vacations Worldwide Corporation

VAC

Marriott Vacations Worldwide Corporation

HOLD

Current Price

$97.00

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
VAC
Founded
2017
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
BEAM
VAC
Price
$26.64
$97.00
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$50.75
$75.13
AVG Volume (30 Days)
2.7M
396.4K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
4.68%
EPS Growth
82.31
N/A
EPS
N/A
0.64
Revenue
$24,000.00
$5,032,000,000.00
Revenue This Year
N/A
$54.23
Revenue Next Year
$33.77
$2.90
P/E Ratio
N/A
$153.05
Revenue Growth
33.33
1.31
52 Week Low
$15.60
$44.58
52 Week High
$38.26
$105.97

Technical Indicators

Market Signals
Indicator
BEAM
VAC
Relative Strength Index (RSI) 33.67 52.49
Support Level $24.80 $93.00
Resistance Level $29.99 $105.97
Average True Range (ATR) 2.21 3.55
MACD -1.00 -0.80
Stochastic Oscillator 4.11 47.47

Price Performance

Historical Comparison
BEAM
VAC

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About VAC Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.

Share on Social Networks: